INTRODUCTION
Tangier disease is a rare disorder of plasma lipid transport characterized by the near absence of plasma high density lipoproteins (HDL).1 Clinical manifestations are related to the storage of cholesteryl esters in reticuloendothelial tissues and the occurrence of sensory and motor neuropathies (1) . Evidence has been provided that patients with Tangier disease have small amounts of HDL in their plasma which is not identical to the normal lipoproteins of this density class (2, 3) . There is an absolute decrease in the amount of Apo A-I and Apo A-II, the major apoproteins of HDL, in Tangier plasma and the Apo A-I appeared disproportionately decreased with respect to Apo A-II (2, 3) . Such a profound change in apoprotein composition undoubtedly alters the physical and metabolic properties of Tangier HDL, but the minute quantities of HDL recoverable from Tangier plasma have generally frustrated attempts to define these changes.
In the present study, we have further examined the chemical and structural features of Tangier HDL. The lipoproteins in this density class proved to be extremely pleomorphic and a lipoprotein form has been identified and characterized which contains only the A-II apoprotein.
METHODS
Patients. Five patients homozygous for Tangier disease (C.N., T.L., P.L., E.G., and J.S.) were donors of the Tangier plasma. Their clinical manifestations have been described in detail in previous reports from our laboratories (2, (4) (5) (6) (7) (8) .
Isolation of lipoproteins. Plasma was collected in 0.01% EDTA by plasmapheresis of patients and normal subjects who had fasted overnight. The background density of the plasma was raised with solid KBr to a calculated density of 1.063 g/ml. The plasma was then centrifuged in a 60 Ti rotor in a Beckman L2 65 B instrument (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) at 60,000 rpm for 16 h (2.44 x 108 g-min). The tubes were sliced 30 mm below the tops and the infranate was adjusted to 1.210 g/ml with additional KBr and then recentrifuged at 60,000 rpm in a 60 Ti rotor for 48 h (7.32 x 108 g-min). The 1.21-g/ml supernatant fraction, obtained by slicing the tubes 20 mm below the tops, was readjusted to d = 1.21 and centrifuged at 40,000 rpm in a 40 rotor for 48 h (3.04 x 108 g-min). Appropriate blanks of identical salt composition and density were included to determine the salt density of supernatant and infranatant fractions after each centrifugation. The centrifuged lipoproteins from the 1.063-1.21-g/ml range (HDL) were used for further fractionation by agarose-column chromatography.
Gel chromatography. HDL were dialyzed against 100 vol of 0.05 M NH4HCO3 buffer, pH 8, containing 0.01% EDTA, and fractionated on a column of Biogel A, 1.5 M, 100-200 mesh (2 x 90 cm) (Bio-Rad Laboratories, Richmond Calif.) equilibrated in the same buffer. The eluate (10 ml/h) was monitored by absorbance at 230 nm. Appropriate column fractions were pooled and concentrated by diaflow ultrafiltration to a final volume of 0.5-1.5 ml.
Analysis of column fractions. The lipoprotein patterns of agarose-column fractions were evaluated by polyacrylamide electrophoresis (separating gel: 3% polyacrylamide, 0.25% N,N'-methylenebisacrylamide) (9) . In this electrophoretic system, HDL migrate rapidly as a sharp single band (ca. 5 cm from the stacking-separating gel interface) and is well separated from very low density lipoproteins (VLDL) and low density lipoproteins. Column fractions, containing material with HDL mobility, were combined and analyzed for their apoprotein composition by analytical polyacrylamide gel electrophoresis in 8 M urea, pH 9.4 (10), or 1% sodium lauryl sulfate at pH 8.2 (11) . HDL apoproteins used as reference material in these studies were isolated by previously described procedures (12) .
Incubation experiments. To investigate the in vitro exchange of C apoproteins (Apo C-II, Apo C-IIIl, and Apo C-III2) from the VLDL to the HDL density range, 125I_ VLDL was incubated with normal and Tangier plasma. VLDL isolated from a nornolipidemic volunteer by ultracentrifugation at d < 1.006 were labeled with 1251 according to the McFarlane technique (13) as modified by Bilheimer et al. (14) . Assuming a mol wt of 300,000 for the entire VLDL apoprotein, the atom/mole ratio of iodine to protein was 0.5. 1 mg of l25I-labeled VLDL protein was added to 50 ml of fresh plasma obtained from Tangier patients (E.G. and J.S.) or fresh normolipidemic control plasma. The plasma was incubated for 1 h at 37°C and the lipoproteins were then isolated by sequential ultracentrifugation at 4°C. Radioactivity of the individual density fractions was measured after dialysis against 100 vol of 0.9% NaCl (Packard auto-gamma scintillation spectrometer, model 5230, Packard Instrument Co., Inc., Downers Grove, Ill.). Individual lipoproteins were delipidated with chloroform-methanol, and the radioactivity of the apoproteins was determined after urea-polyacrylamide electrophoresis in 5-mm gel slices. The chloroform-methanol phase was also assayed for radioactive content.
Reassembly experiments. Apoprotein A-II, isolated from one of the patients homozygous for Tangier disease (C.N.) and control patients, was tested for its ability to form a protein-lipid complex with sphingomyelin (SPM). A 3H label was chemically introduced into the choline moiety of SPM (beef brain, Sigma Chemical Co., St. Louis, Mo.) (15) .
[N-C3H3-choline]SPM (sp act 2.8 x 105 cpm./mol) was purified by silica-gel chromatography and subsequently used as sonicated dispersion for recombination with Apo A-II as previously described (16) . Lipid-protein complexes were isolated by sequential ultracentrifugation between d = 1.063-1.21 g/ml and subsequent agarose-gel chromatography (16) . Ultracentrifugal and column fractions were analyzed for phospholipid by determination of radioactivity, and for protein by the method of Lowry et al. (17) . Spectroscopic methods. Samples analyzed by circular dichroism spectroscopy were dialyzed against 100 vol of 0.05 M sodium phosphate buffer, pH 8. Spectra were recorded using a Cary 60 spectropolarimeter (Cary Instruments, Fairfield, N. J.) equipped with Pockels cell and standardized with potassium dichromate. The spectra reported are the mean of four repetitive analyses of each preparation. The signal-to-noise ratio was always greater than 10:1. The mean residue ellipticity in units of degree/square centimeter per decimole was calculated from 0 = (MRW) (0) X°/10 lc where (0 A°is the observed ellipticity in degrees at wavelength; 1, the optical path in centimeters; c, the concentration in grams per milliliter; and MRW, the mean residue weight calculated from amino-acid analyses (Apo A-II: 117). The degree of alpha-helical structure in the individual samples was estimated at 222 nm assuming a value of 29,000 for a completely helical protein and little or no residues in f3-structure (19) . Fluorescence measurements were made in the Turner model 210 corrected spectrofluorometer (G. K. Turner Associates, Palo Alto, Calif.) equipped with thermostated cell holders (20) .
Electron microscopy. Lipoprotein fractions were dialyzed against 1% ammonium acetate buffer, pH 7.4, containing 5 mg/l EDTA. Fractions were diluted and mixed with an equal volume of 2% sodium phosphotungstate, pH 7.4, to a final concentration of 50-250 ug/ml. A droplet was placed on a Fornvar/carbon-coated grid, excess fluid was removed with filter paper, and the negatively stained preparation was then examined in an electron microscope. Lipoprotein size distribution was determined from measurements of 200-800 particles.
Other methods. (22), using the "four hour hydrolyzate system" (23) . No correction was made for amino acid degradation or incomplete protein hydrolysis.
Lipoproteins were delipidated using a chloroform: methanol, 2:1, solvent system (18) . Lipid phosphorus was assayed with the malachite green reagent (24, 25) and phospholipid was estimated as the product of lipid phosphorus x 25. Individual phospholipids were separated and identified by thin-layer chromatography using a solvent system of chloroform:methanol:water, 65:25:4. Free cholesterol and cholesteryl esters were separated by thin-layer chromatography (petroleum ether:ethyl ether:acetic acid, 70:30:1), scraped off the plates, and quantitated by the Zak et al. procedure (26) .
Immunoelectrophoresis and double-diffusion were performed in 1% agarose buffered with 0.1 M sodium barbital, pH 8.0. All antisera employed were specific for one apolipoprotein.
RESULTS
Characterization ofTangier HDL. The 1.063-1.21-g/ml ultracentrifugal fractions from the plasma of controls and three patients with Tangier disease were examined by an electron microscope. Control preparations were homogeneous, containing spherical particles of 90-150 A diameter (Fig. 1) spherical particles were present in the Tangier HDL (Fig. 1) . Tangier HDL eluted in three major and several minor peaks from an 8% agarose column (Fig. 2) . Fractions I and II, emerging at or near the column void volumn, contained particles with diameters of >200 A. The material in these fractions was either retained in the stacking gel or had low (J3) mobility when examined by electrophoresis in 3% polyacrylamide (Fig. 3) . Fractions IV-VI were inconsistently observed and, although occasionally generating bands on electrophoresis (Fig. 3) , contained no structural elements identifiable by electron microscopy. These fractions were not further investigated. Immunochemically, none of these fractions contained Apo A-I or Apo A-II antigenicity.
Fraction III, which upon rechromatography eluted in the same position from the agarose column, contained mostly spherical particles ofabout 60 A diameter (Fig. 4) with alpha mobility in polyacrylamide electrophoresis (Fig. 3) . These alpha-migrating lipoproteins were reproducibly isolated from the HDL of the five Tangier patients and were the subject of detailed analysis.
The protein composition of the agarose fraction III was qualitatively assessed by electrophoresis in 10% acrylamide gels containing 0.1% sodium lauryl sulfate. The major HDL apoproteins, Apo A-I and Apo A-II, have characteristic mobilities and the width and intensity of the bands in control HDL reflects the 3:1, Apo A-I:Apo A-II, weight ratio (Fig. 5) . Only Apo A-II was identified when the agarose column fraction III, without organic solvent delipidation, was similarly examined (HDLTG, Fig. 5 Neither immunoelectrophoresis nor double immunodiffusion revealed the presence of Apo A-I in agarose fraction III derived from Tangier HDL when specific antisera to Apo A-I were employed (not shown). Antisera to Apo A-II, however, gave a strong precipitin line when tested against Tangier HDL or agarose fraction III (3). In two of the Tangier patients (E.G., J.S.), the absence of Apo A-I from Tangier HDL could also be demonstrated by specific radioimmunoassay (3) . The absolute amount of Apo A-II contained in the Tangier HDL ultracentrifugal fraction as assessed by radioimmunoassay (3) (1.1 mg/dl, patient J.S.) was comparable to the amount of Apo A-II recovered in agarose fraction III (0.95 mg/dl). In four preparations (J.S., E.G.), the amount of Apo A-II recovered in agarose fraction III varied from 0. A-II-containing lipoprotein as isolated by ultracentrifugation and agarose-column chromatography. Apo A-II contains tyrosine but is the only known apolipoprotein with no tryptophan. The fluorescence spectrum of the Tangier Apo A-TI particle (HDLTG, Fig. 6 ) excluded a significant content of any tryptophan-containing protein. The emission peak at 305 nm and the spectra above and below 320 nm deviated only slightly from that of N-acetyl tyrosinamide (27) indicating the virtual absence of tryptophanyl residues. In normal HDL, the tryptophanyl residues, primarily in Apo A-I, contribute more than 90% of the fluorescence at 320 nm and -100% at 328 nm.
The secondary structure of the protein in agarose fraction III was evaluated by circular dichroism measurements in the far ultraviolet wavelength region. The large negative ellipticities at 208 and 220 nm indicate that the Apo A-II as a constituent of this Tangier lipoprotein has a high helical content. At 220 nm the Apo A-II in HDLTG (agarose fraction III, Fig. 7 ) had a mean residue ellipticity of 21,800, whereas that of lipid-free Apo A-II, at pH 7.4, was 14,500. The former value suggests a helical content of about 75% for the Tangier Apo A-II in HDLTG.
The lipid composition of the Tangier Apo A-IIcontaining particle (HDLTG) was quite similar to that of normal HDL (Table I) . Phosphatidyl choline and SPM were the most abundant phospholipids, and their relative proportions were virtually identical to control HDL. Cholesteryl esters were the major neutral lipids and the quantity of free cholesterol was only slightly higher than normal (Table I) . The (16, (28) (29) (30) . When Tangier Apo A-TI was recombined with [3H]SPM, complexes with a SPM:protein molar ratio of 37:1 were isolated after sequential flotation in the ultracentrifuge (Table III) . The control Apo A-II-SPM preparation had a comparable lipid-protein ratio. Similar stoichiometry was observed when ultracentrifugation was followed by agarose-column fractionation of the recombinant particles. Examination by electron microscopy showed that the Tangier Apo A-II particles were discoidal structures similar to those previously described; the Tangier and normal Apo A-TI disks were 70-75 A wide.
1251-VLDL incubation experiments. The distribution of 1251 radioactivity in the VLDL, low density Table IV . In contrast to the radioactivity distribution of normolipidemic plasma, only small amounts of radioactivity were associated with the d = 1.063-1.21 g/ml fraction of Tangier plasma. About 28% of the radioactivity in the original VLDL was found collectively in the C apoproteins (Apo C-II, Apo C-IIIl, and Apo C-Ill2). After in vitro incubation of 1251-labeled VLDL with normal plasma, 55% of the radioactivity originally associated with the C apoproteins in VLDL was transferred to the HDL density region. In Tangier HDL, however, the radioactivity was not confined to the C apoproteins, but rather to Apo B or other apoproteins at the interface of stacking and running gel which were present as contaminating fraction.
The failure to detect C apoproteins as protein constituents of Tangier HDL cannot be explained on the basis of the total absence of these proteins from Tangier plasma, since their presence can be demonstrated by coelectrophoresis of Tangier VLDL apoproteins with normal VLDL apoproteins in urea-polyacrylamide disc gels (not shown).
DISCUSSION
This study was designed to further clarify the nature of HDL in Tangier disease. We have previously demonstrated by radioimmunoassay determination of A apoproteins in Tangier plasma, that Apo A-I, the major apoprotein of normal HDL, is almost exclusively confined to the d > 1.21 g/ml ultracentrifugal fraction and absent from the d = 1.063-1.21 g/ml fraction (3) . By contrast, significant amounts of Apo A-II were present in the HDL density fraction of Tangier plasma (3) . The presence of apoproteins antigenically related to normal HDL was recognized in early studies of Tangier plasma (31, 32) . The striking pleomorphism of the lipoproteins of density 1.063-1.21 g/ml (Fig.  1) was not appreciated, however, and all of the apoproteins normally found in HDL were considered to be associated with Tangier HDL, albeit in abnormal proportions (2) .
Fractionation of the 1.063-1.21 gIml lipoproteins by agarose-column chromatography (Fig. 2) demonstrates that only a relatively minor quantity of Tangier "HDL" has alpha mobility (Fig. 3) . Morphologically, these alpha-migrating lipoproteins are tiny spherical particles, 55-75 A, overlapping in size only the smallest HDL found in normal plasma (Fig. 4) . Their gross (Fig. 7) , whereas lipid-free Apo A-II contains only 35-45% alpha helix as judged by circular dichroic spectra (16, 28, 35) . Reassembly of Apo A-II with lipids in vitro can increase the alpha-helix content to 60-65% (16, 28) and the value of 75% in the Tangier Apo A-II particle approximates that estimated for the protein in native HDL (36) .
The Apo A-II isolated from Tangier HDL appears to recombine normally with SPM to form discoidal lipoprotein particles. Moreover, the major peptides released on tryptic digestion of Tangier and control Apo A-II are indistinguishable. These findings mitigate against the possibility that a structurally abnormal Apo A-II is elaborated in Tangier disease but the question will not be completely resolved until the amino acid sequence of Tangier Apo A-II is determined.
Of particular interest was the finding that besides Apo A-I, the C apoproteins were also absent from the Tangier Apo A-II particle. It must be concluded that the Apo A-Il particle in Tangier plasma is incapable of integrating C apoproteins into its structure and it appears that the C apoproteins do not form independent HDL unassociated with the normal proteins and lipids of this density class. The transfer and exchange of C apoproteins from HDL to VLDL, and vice versa, has been previously recognized as a physiological mechanism in the catabolism of triglyceride-rich lipoproteins (37) . The impairment of this mechanism might explain the hypertriglyceridemia and fasting chylomicronemia observed in patients with Tangier disease.
Unliked discoidal HDL observed in lecithin-cholesterol acyltransferase deficiency (38) (39) (40) (41) , in cholestasis in man (42) (43) (44) , in cholesterol-fed guinea pigs (45, 46) , and in rat liver perfusates (47) , Tangier HDL particles are of spherical, pseudomicellar shape containing a substantial amount of cholesteryl esters. Previous studies have suggested an essential role for lecithincholesterol acyltransferase (LCAT) in the generation of pseudomicellar particles of plasma HDL as well as for Apo A-I as a cofactor in the LCAT reaction (47, 48) . Apparently, the small amounts of Apo A-I in Tangier plasma (<1 mg/dl) are sufficient to maintain the conversion of cholesterol and lecithin to cholesteryl esters and lysolecithin, and LCAT activity is present in spite of the absence of normal HDL. This could also be confirmed by in vitro measurements of LCAT in Tangier plasma. 2 We have no experimental data bearing on the origin of the Apo A-II-containing lipoprotein particles in Tangier plasma. They may be products of a mutant gene coding an abnormal lipoprotein form. They may reflect the failure of a structurally abnormal Apo A-I to associate with normal HDL particles. On the other hand, they may represent a normal secretory HDL subpopulation, or a normal HDL degradation product whose presence is masked in normal plasma by an overwhelming amount of other HDL.
